Exchange Traded Concepts’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Exchange Traded Concepts’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-186,232	Closed	-$296K	–	1322
2024 Q1	$296K	Buy	186,232 +79,213	+74%	+$117K	0.01%	801
2023 Q4	$91.9K	Buy	107,019 +27,137	+34%	+$23.8K	﹤0.01%	896
2023 Q3	$85.5K	Buy	79,882 +40,066	+101%	+$82.9K	﹤0.01%	949
2023 Q2	$103K	Buy	+39,816	New	+$142K	﹤0.01%	938

Exchange Traded Concepts's NGM Position: Q2 2024 in Review

Exchange Traded Concepts sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 186,232 shares — an estimated $296K sold.

Exchange Traded Concepts first reported a position in NGM in Q2 2023 and held it in 4 quarters. The position peaked at $296K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Exchange Traded Concepts reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Exchange Traded Concepts sold 186,232 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $296K.
Exchange Traded Concepts first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
Exchange Traded Concepts's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $296K in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Exchange Traded Concepts's 13F filing for Q2 2024, filed 13 Aug 2024.